Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
AC, adult, affiliate, Alan, allele, ASU, auditor, Bachelor, bilirubin, blood, body, Bribery, bribing, bulk, Bulletin, bunionectomy, Bureau, Buyer, calendar, Chan, clarity, closure, Congressional, constipation, convicted, Council, courtesy, CRTR, cum, deficit, deuterated, disorder, displace, distal, distinct, domain, dry, DTA, Eloxx, Ethicon, experimental, eye, FCPA, Fellow, fiber, Garber, Graney, Guarantor, guide, hemoglobin, hemoglobinopathy, Henry, Immune, ImmunoGen, ingredient, intermediate, intestinal, investee, Ironwood, irreversible, Jr, jugular, Kaiser, Kennedy, Lastly, laude, Leonard, longest, lt, Mallinckrodt, mild, monotherapy, morbidity, mortality, multiplied, nausea, neuropathic, neuropathy, nineteen, Notwithstanding, nutritional, obligor, oropharyngeal, pancreatic, PCAOB, pimodivir, provisional, Provost, PSU, punishable, pyrexia, QD, quickly, rash, readily, reassessed, recall, reconsideration, reject, remitted, reputable, restarted, revaluation, robust, rolling, roughly, Royal, SA, SAB, score, SEC, shipment, Society, Stanford, Stern, summa, surgery, surgical, sweat, SYMDEKO, SYMDEKOTM, syndrome, tablet, therefrom, throat, Tom, treaty, UK, unaffected, unlawful, vein, verify, weighing, weight, willingly, younger
Removed:
Accountability, accrual, addressing, advantage, advice, Affordability, Africa, aggressively, al, amending, ascribed, automatically, automation, Bertrand, bifurcation, binding, bioavailability, Boger, bond, broadly, called, Cambridge, caption, carryforward, cervical, clarify, CMS, collaborated, Commonwealth, complaint, concealing, Conservation, consistently, consultation, converting, convey, court, decommissioning, defendant, defraud, deliberate, deterioration, discovering, disputed, disregard, district, Dohme, dose, dossier, doubt, draft, East, education, embezzlement, embezzling, enjoy, eventually, falsifying, falsity, FDASIA, felony, fill, foot, footage, founder, futility, gating, Genzyme, gift, HCV, headed, heavily, HIPAA, history, IBEW, Immunology, INCIVO, incremental, Inflammation, Inspector, institutional, insurer, invalidity, IRB, Jersey, Joshua, Justice, Kendall, lawful, lawsuit, liaison, Loi, lowering, magazine, Middle, misapplying, misleading, modeled, moiety, motion, Move, nucleotide, obstructing, Occupational, occupied, occupy, occupying, offense, Pharmaceutica, philosophy, pivotal, plaintiff, Portability, potency, precision, promulgation, purported, putative, Rahway, ratable, reconciled, redeemed, reflection, regional, register, rentable, representative, requested, resolve, resubmit, reviewing, scheme, Scott, selection, sequential, serve, Sharp, shorten, shortened, simplification, South, stability, stealing, subleased, subordinated, Switzerland, thereunder, top, Trademark, transitioning, Trust, truth, unannounced, unbenefitted, undergo, unspecified, validation, Wesleyan, withdrew, writing
Filing tables
Filing exhibits
Related press release
Associated VRTX transcripts
VRTX similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1) | Registration Statement (Form S-3 No. 333-211096) of Vertex Pharmaceuticals Incorporated, |
(2) | Registration Statement (Form S-8 Nos. 333-134482, 333-150946, 333-160442, 333-166803 and 333-184787) pertaining to the Vertex Pharmaceuticals Incorporated Amended and Restated 2006 Stock and Option Plan (formerly known as the Vertex Pharmaceuticals Incorporated 2006 Stock and Option Plan), |
(3) | Registration Statement (Form S-8 No. 333-184784) pertaining to the Vertex Pharmaceuticals Incorporated Employee Stock Purchase Plan, and |
(4) | Registration Statement (Form S-8 Nos. 333-219559, 333-188737, 333-197466 and 333-206075) pertaining to the Amended and Restated Vertex Pharmaceuticals Incorporated 2013 Stock and Option Plan (formerly known as the Vertex Pharmaceuticals Incorporated 2013 Stock and Option Plan); |
of our reports dated February 14, 2018, with respect to the consolidated financial statements of Vertex Pharmaceuticals Incorporated and the effectiveness of internal control over financial reporting of Vertex Pharmaceuticals Incorporated, included in this Annual Report (Form 10-K) of Vertex Pharmaceuticals Incorporated for the year ended December 31, 2017.
/s/ Ernst & Young LLP
Boston, Massachusetts
February 14, 2018